(ZBRA) Zebra Technologies - Ratings and Ratios
Barcode Printers, RFID Readers, Mobile Computers, Scanners, Software
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 36.5% |
| Value at Risk 5%th | 55.2% |
| Relative Tail Risk | -8.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.79 |
| Alpha | -64.20 |
| CAGR/Max DD | -0.08 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.444 |
| Beta | 1.684 |
| Beta Downside | 1.925 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.29% |
| Mean DD | 20.06% |
| Median DD | 20.81% |
Description: ZBRA Zebra Technologies January 03, 2026
Zebra Technologies (NASDAQ: ZBRA) delivers enterprise-asset-intelligence solutions across two segments-Asset Intelligence & Tracking and Enterprise Visibility & Mobility-by designing, manufacturing, and servicing a broad portfolio that includes label and card printers, RFID-enabled devices, rugged mobile computers, barcode scanners, and cloud-based software subscriptions.
In FY 2023 the company generated roughly **$9.2 billion** in revenue, with the **RFID and real-time location systems (RTLS) businesses driving a 14 % YoY increase**, reflecting heightened demand for automated inventory and asset visibility in logistics and healthcare. The segment’s operating margin hovered around **13 %**, underscoring strong pricing power amid a competitive landscape.
Key macro drivers for Zebra include the **global e-commerce surge (projected to grow >10 % CAGR through 2027)**, which fuels label-printing and barcode-scanning volumes, and **persistent labor shortages** that accelerate adoption of RFID-based automation and prescriptive analytics to reduce manual handling costs. Additionally, the broader **IoT and Industry 4.0 trends** support the company’s push into sensor-enabled tags and cloud-managed services.
For a deeper, data-driven valuation framework, you may find ValueRay’s analytical tools worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (512.0m TTM) > 0 and > 6% of Revenue (6% = 315.3m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA -0.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 18.52% (prev 12.26%; Δ 6.25pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 866.0m > Net Income 512.0m (YES >=105%, WARN >=100%) |
| Net Debt (1.31b) to EBITDA (1.06b) ratio: 1.23 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.61 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (51.8m) change vs 12m ago -0.21% (target <= -2.0% for YES) |
| Gross Margin 48.39% (prev 47.53%; Δ 0.86pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 66.70% (prev 60.55%; Δ 6.15pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.62 (EBITDA TTM 1.06b / Interest Expense TTM 194.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.91
| (A) 0.12 = (Total Current Assets 2.58b - Total Current Liabilities 1.60b) / Total Assets 8.07b |
| (B) 0.65 = Retained Earnings (Balance) 5.21b / Total Assets 8.07b |
| (C) 0.11 = EBIT TTM 896.0m / Avg Total Assets 7.88b |
| (D) 1.19 = Book Value of Equity 5.15b / Total Liabilities 4.32b |
| Total Rating: 4.91 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.89
| 1. Piotroski 7.0pt |
| 2. FCF Yield 5.71% |
| 3. FCF Margin 15.07% |
| 4. Debt/Equity 0.63 |
| 5. Debt/Ebitda 1.23 |
| 6. ROIC - WACC (= -0.92)% |
| 7. RoE 14.05% |
| 8. Rev. Trend -34.78% |
| 9. EPS Trend -37.42% |
What is the price of ZBRA shares?
Over the past week, the price has changed by +2.71%, over one month by -5.14%, over three months by -7.97% and over the past year by -32.02%.
Is ZBRA a buy, sell or hold?
- Strong Buy: 9
- Buy: 2
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ZBRA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 350.8 | 35.2% |
| Analysts Target Price | 350.8 | 35.2% |
| ValueRay Target Price | 248.7 | -4.1% |
ZBRA Fundamental Data Overview January 09, 2026
P/E Forward = 16.7504
P/S = 2.3895
P/B = 3.339
P/EG = 0.87
Beta = 1.683
Revenue TTM = 5.25b USD
EBIT TTM = 896.0m USD
EBITDA TTM = 1.06b USD
Long Term Debt = 2.11b USD (from longTermDebt, last quarter)
Short Term Debt = 102.0m USD (from shortTermDebt, last quarter)
Debt = 2.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.31b USD (from netDebt column, last quarter)
Enterprise Value = 13.86b USD (12.56b + Debt 2.36b - CCE 1.05b)
Interest Coverage Ratio = 4.62 (Ebit TTM 896.0m / Interest Expense TTM 194.0m)
EV/FCF = 17.50x (Enterprise Value 13.86b / FCF TTM 792.0m)
FCF Yield = 5.71% (FCF TTM 792.0m / Enterprise Value 13.86b)
FCF Margin = 15.07% (FCF TTM 792.0m / Revenue TTM 5.25b)
Net Margin = 9.74% (Net Income TTM 512.0m / Revenue TTM 5.25b)
Gross Margin = 48.39% ((Revenue TTM 5.25b - Cost of Revenue TTM 2.71b) / Revenue TTM)
Gross Margin QoQ = 48.03% (prev 47.64%)
Tobins Q-Ratio = 1.72 (Enterprise Value 13.86b / Total Assets 8.07b)
Interest Expense / Debt = 5.04% (Interest Expense 119.0m / Debt 2.36b)
Taxrate = 36.48% (58.0m / 159.0m)
NOPAT = 569.2m (EBIT 896.0m * (1 - 36.48%))
Current Ratio = 1.61 (Total Current Assets 2.58b / Total Current Liabilities 1.60b)
Debt / Equity = 0.63 (Debt 2.36b / totalStockholderEquity, last quarter 3.75b)
Debt / EBITDA = 1.23 (Net Debt 1.31b / EBITDA 1.06b)
Debt / FCF = 1.65 (Net Debt 1.31b / FCF TTM 792.0m)
Total Stockholder Equity = 3.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.50% (Net Income 512.0m / Total Assets 8.07b)
RoE = 14.05% (Net Income TTM 512.0m / Total Stockholder Equity 3.64b)
RoCE = 15.58% (EBIT 896.0m / Capital Employed (Equity 3.64b + L.T.Debt 2.11b))
RoIC = 9.79% (NOPAT 569.2m / Invested Capital 5.82b)
WACC = 10.71% (E(12.56b)/V(14.92b) * Re(12.12%) + D(2.36b)/V(14.92b) * Rd(5.04%) * (1-Tc(0.36)))
Discount Rate = 12.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.12%
[DCF Debug] Terminal Value 59.09% ; FCFF base≈782.4m ; Y1≈513.6m ; Y5≈234.3m
Fair Price DCF = 36.22 (EV 3.14b - Net Debt 1.31b = Equity 1.83b / Shares 50.7m; r=10.71% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -37.42 | EPS CAGR: -48.11% | SUE: -4.0 | # QB: 0
Revenue Correlation: -34.78 | Revenue CAGR: -2.78% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=4.10 | Chg30d=+0.112 | Revisions Net=+3 | Analysts=15
EPS next Year (2026-12-31): EPS=17.70 | Chg30d=-0.027 | Revisions Net=-2 | Growth EPS=+11.8% | Growth Revenue=+10.0%
Additional Sources for ZBRA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle